重症研究分析的新趋势:贝叶斯统计
本文介绍贝叶斯统计在重症研究中的应用:其包含先验概率、观测数据似然和后验概率三部分,用概率分布而非单一 P 值提供解释。ANDROMEDA-SHOCK 试验原频率学分析显示外周灌注导向复苏较乳酸导向复苏死亡率降低有临床意义但未达统计学显著,Zampieri 等的贝叶斯再分析显示 28 天和 90 天死亡率降低的后验概率持续>90%。Sidebotham 等提示低受试者易感性可能降低试验效能,Hatton 等显示贝叶斯推理可提供更清晰的获益与危害估计,创伤 REBOA 的随机对照试验也用贝叶斯方法分析。作者认为贝叶斯统计在 21 世纪第二季度将越来越多用于原始研究,提高结果可解释性。
要点
- ANDROMEDA-SHOCK 原频率学分析:外周灌注导向复苏较乳酸导向复苏死亡率降低有临床意义但未达统计学显著。
- Zampieri 等贝叶斯再分析:外周灌注导向复苏降低 28 天和 90 天死亡率的后验概率持续>90%。
- Sidebotham 等提示低受试者易感性可能降低试验效能,即使干预有效。
- Hatton 等显示贝叶斯推理通过提供更清晰的获益与危害估计改善外科判断。
- 创伤 REBOA 的一项实施良好的随机对照试验也采用贝叶斯方法分析。
研究设计与关键结果
- ANDROMEDA-SHOCK 试验原用频率学方法分析,显示外周灌注导向复苏较乳酸导向治疗死亡率降低有临床意义但未达统计学显著。
- Zampieri 等的贝叶斯再分析显示外周灌注导向复苏降低 28 天和 90 天死亡率的后验概率持续>90%。
- Sidebotham 等提示低受试者易感性可能降低试验效能,尽管干预有效,并建模估计不同假设下统计学显著结果的比例。
- Hatton 等显示贝叶斯推理通过提供更清晰的获益与危害估计改善外科判断。
- 创伤中 REBOA 的一项实施良好的随机对照试验也使用贝叶斯方法分析。
对床旁实践的改变
- 作者认为贝叶斯统计在 21 世纪第二季度将越来越多用于原始研究,其整合提高结果可解释性并弥合统计推断与临床推理之间的差距。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「证据类型、等级与局限」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Biostatistics plays an essential role in medical research. In the 20th century, frequentist statistics dominated clinical investigations. In this approach, inference is based on the probability of obtaining the observed data, assuming that the null hypothesis is either accepted or rejected. The Bayesian statistical inference is considerably different. It involves three main components: prior probability, likelihood of observed data, and posterior probability. Priors can enhance interpretation by incorporating existing knowledge. The posterior distribution provides rich interpretive value and uses probability distributions rather than single p-values. The ANDROMEDA-SHOCK trial, originally analyzed with frequentist methods, showed a clinically meaningful but not statistically significant mortality reduction with peripheral perfusion-targeted resuscitation compared to lactate-targeted therapy. A Bayesian reanalysis by Zampieri et al. revealed a consistently high posterior probability (over 90 %) that peripheral perfusion-targeted resuscitation reduces mortality at both 28 and 90 days, providing stronger evidence of its benefit. Sidebotham et al. suggested that low participant susceptibility may reduce trial power, despite effective interventions. They modeled scenarios to estimate the proportion of statistically significant results under various assumptions. Hatton et al. showed that Bayesian reasoning can improve surgical judgment by offering clearer estimates of benefit and harm. Even a well-conducted RCT on REBOA in trauma was analyzed using a Bayesian approach. This highlights the growing expectation that Bayesian statistics will be increasingly used in original investigations during the second quarter of the 21st century. Its integration into clinical research improves the interpretability of the results and bridges the gap between statistical inference and clinical reasoning.
参考来源
- Demirtakan T. A trending approach for analysis in critical care research: Bayesian statistics. Am J Emerg Med. 2025. PMID: 40579329. doi:10.1016/j.ajem.2025.06.052
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。